Skip to main content
Erschienen in: Current Sleep Medicine Reports 2/2024

05.02.2024 | REVIEW

A Topical Review on Transcranial Magnetic Stimulation in Restless Legs Syndrome

verfasst von: Giuseppe Lanza, Maria P. Mogavero, Bartolo Lanuzza, Mariangela Tripodi, Mariagiovanna Cantone, Manuela Pennisi, Rita Bella, Raffaele Ferri

Erschienen in: Current Sleep Medicine Reports | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This topical review aims to explore the potential of transcranial magnetic stimulation (TMS) as both a neurophysiological diagnostic tool and a novel therapeutic approach for restless legs syndrome (RLS).

Recent Findings

Overall, TMS data suggest that RLS should be regarded as a complex sensory-motor disorder in which cortical, subcortical, and spinal cord generators are involved, resulting in an enhanced cortical excitation and decreased inhibition. In this context, RLS symptoms are likely to arise at different levels of a complex network, eventually resulting in a modified, possibly temporary and circadian, excitability of a multifaceted neurophysiological drive. Therapeutically, the stimulation of the primary motor cortex (especially of the leg area), unilaterally or bilaterally, as well as of the primary somatosensory cortex (at least unilaterally), seems to safely reduce subjective symptoms and severity scale scores, with effects lasting for up to weeks.

Summary

This review delves into the pathophysiology of RLS through the “looking glass” of TMS and the existing clinical evidence and neuroplastic changes induced by TMS, as well as into the current challenges for clinicians and future directions for researchers. By examining all these aspects, the review sheds light on the promise and limitations of applying TMS in the diagnostic refinement and therapeutic management of RLS.
Literatur
1.
Zurück zum Zitat Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15:860–73. https://doi.org/10.1016/j.sleep.2014.03.025.CrossRefPubMed Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15:860–73. https://​doi.​org/​10.​1016/​j.​sleep.​2014.​03.​025.CrossRefPubMed
7.
11.••
Zurück zum Zitat Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics: J Am Soc Exp NeuroTherapeutics. 2021;18:140–55. https://doi.org/10.1007/s13311-021-01019-4. A detailed “state-of-art” of the current treatments of RLS, that also facilitates the identification of new therapeutic approaches. Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics: J Am Soc Exp NeuroTherapeutics. 2021;18:140–55. https://​doi.​org/​10.​1007/​s13311-021-01019-4. A detailed “state-of-art” of the current treatments of RLS, that also facilitates the identification of new therapeutic approaches.
21.•
Zurück zum Zitat Mogavero MP, Mezzapesa DM, Savarese M, DelRosso LM, Lanza G, Ferri R. Morphological analysis of the brain subcortical gray structures in restless legs syndrome. Sleep Med. 2021;88:74–80. https://doi.org/10.1016/j.sleep.2021.10.025. RLS pathophysiology might include not only the hypothalamus-spinal dopaminergic circuit, but also the basal ganglia and part of the limbic system.CrossRefPubMed Mogavero MP, Mezzapesa DM, Savarese M, DelRosso LM, Lanza G, Ferri R. Morphological analysis of the brain subcortical gray structures in restless legs syndrome. Sleep Med. 2021;88:74–80. https://​doi.​org/​10.​1016/​j.​sleep.​2021.​10.​025. RLS pathophysiology might include not only the hypothalamus-spinal dopaminergic circuit, but also the basal ganglia and part of the limbic system.CrossRefPubMed
26.
Zurück zum Zitat Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol : Off J Int Fed Clin Neurophysiol. 2015;126:1071–107. https://doi.org/10.1016/j.clinph.2015.02.001.CrossRef Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An updated report from an I.F.C.N. Committee. Clin Neurophysiol : Off J Int Fed Clin Neurophysiol. 2015;126:1071–107. https://​doi.​org/​10.​1016/​j.​clinph.​2015.​02.​001.CrossRef
28.
Zurück zum Zitat Lanza G, Arico D, Lanuzza B, Cosentino FII, Tripodi M, Giardina F, et al. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration? Sleep. 2020;43. https://doi.org/10.1093/sleep/zsz242. Lanza G, Arico D, Lanuzza B, Cosentino FII, Tripodi M, Giardina F, et al. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration? Sleep. 2020;43. https://​doi.​org/​10.​1093/​sleep/​zsz242.
30.••
Zurück zum Zitat Vucic S, Stanley Chen KH, Kiernan MC, Hallett M, Benninger DH, Di Lazzaro V, et al. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2023;150:131–75. https://doi.org/10.1016/j.clinph.2023.03.010. Updated guidelines covering theoretical, physiological, and practical aspects of non-invasive stimulation of the nervous system.CrossRef Vucic S, Stanley Chen KH, Kiernan MC, Hallett M, Benninger DH, Di Lazzaro V, et al. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2023;150:131–75. https://​doi.​org/​10.​1016/​j.​clinph.​2023.​03.​010. Updated guidelines covering theoretical, physiological, and practical aspects of non-invasive stimulation of the nervous system.CrossRef
31.••
Zurück zum Zitat Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2020;131:474–528. https://doi.org/10.1016/j.clinph.2019.11.002. International guidelines on the use of repetitive transcranial magnetic stimulation in neurological and neuropsychiatric diseases, along with level of evidence.CrossRef Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2020;131:474–528. https://​doi.​org/​10.​1016/​j.​clinph.​2019.​11.​002. International guidelines on the use of repetitive transcranial magnetic stimulation in neurological and neuropsychiatric diseases, along with level of evidence.CrossRef
35.
39.
Zurück zum Zitat Scalise A, Pittaro-Cadore I, Golob EJ, Gigli GL. Absence of postexercise and delayed facilitation of motor cortex excitability in restless legs syndrome: evidence of altered cortical plasticity? Sleep. 2006;29:770–5.PubMed Scalise A, Pittaro-Cadore I, Golob EJ, Gigli GL. Absence of postexercise and delayed facilitation of motor cortex excitability in restless legs syndrome: evidence of altered cortical plasticity? Sleep. 2006;29:770–5.PubMed
46.•
Zurück zum Zitat Lanza G, Fisicaro F, Cantone M, Pennisi M, Cosentino FII, Lanuzza B, et al. Repetitive transcranial magnetic stimulation in primary sleep disorders. Sleep Med Rev. 2023;67:101735. https://doi.org/10.1016/j.smrv.2022.101735. A very recent review summarizing the current evidence on the use of individually-tailored repetitive transcranial magnetic stimulation for treating primary sleep disorders.CrossRefPubMed Lanza G, Fisicaro F, Cantone M, Pennisi M, Cosentino FII, Lanuzza B, et al. Repetitive transcranial magnetic stimulation in primary sleep disorders. Sleep Med Rev. 2023;67:101735. https://​doi.​org/​10.​1016/​j.​smrv.​2022.​101735. A very recent review summarizing the current evidence on the use of individually-tailored repetitive transcranial magnetic stimulation for treating primary sleep disorders.CrossRefPubMed
55.•
Zurück zum Zitat Antelmi E, Rocchi L, Latorre A, Belvisi D, Magrinelli F, Bhatia KP, et al. Restless legs syndrome: known knowns and known unknowns. Brain Sci. 2022;12. https://doi.org/10.3390/brainsci12010118. RLS may arise from neurochemical dysfunction and abnormal excitability across different brain structures. Antelmi E, Rocchi L, Latorre A, Belvisi D, Magrinelli F, Bhatia KP, et al. Restless legs syndrome: known knowns and known unknowns. Brain Sci. 2022;12. https://​doi.​org/​10.​3390/​brainsci12010118​. RLS may arise from neurochemical dysfunction and abnormal excitability across different brain structures.
59.•
Zurück zum Zitat Norred MA, Haselden LC, Sahlem GL, Wilkerson AK, Short EB, McTeague LM, et al. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021;14:1508–10. https://doi.org/10.1016/j.brs.2021.09.007. A relevant study suggesting that, likely, the two treatments can be safely given together, with potentially additive efficacy on both sleep and affective disorders.CrossRefPubMedPubMedCentral Norred MA, Haselden LC, Sahlem GL, Wilkerson AK, Short EB, McTeague LM, et al. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021;14:1508–10. https://​doi.​org/​10.​1016/​j.​brs.​2021.​09.​007. A relevant study suggesting that, likely, the two treatments can be safely given together, with potentially additive efficacy on both sleep and affective disorders.CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMSCG. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2009;120:2008–39. https://doi.org/10.1016/j.clinph.2009.08.016. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMSCG. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2009;120:2008–39. https://​doi.​org/​10.​1016/​j.​clinph.​2009.​08.​016.
66.•
Zurück zum Zitat Rossi S, Antal A, Bestmann S, Bikson M, Brewer C, Brockmoller J, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2021;132:269–306. https://doi.org/10.1016/j.clinph.2020.10.003. An update of the ten-year-old safety guidelines for the use of transcranial magnetic stimulation in research and clinical settings.CrossRef Rossi S, Antal A, Bestmann S, Bikson M, Brewer C, Brockmoller J, et al. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clin Neurophysiol: Off J Int Fed Clin Neurophysiol. 2021;132:269–306. https://​doi.​org/​10.​1016/​j.​clinph.​2020.​10.​003. An update of the ten-year-old safety guidelines for the use of transcranial magnetic stimulation in research and clinical settings.CrossRef
Metadaten
Titel
A Topical Review on Transcranial Magnetic Stimulation in Restless Legs Syndrome
verfasst von
Giuseppe Lanza
Maria P. Mogavero
Bartolo Lanuzza
Mariangela Tripodi
Mariagiovanna Cantone
Manuela Pennisi
Rita Bella
Raffaele Ferri
Publikationsdatum
05.02.2024
Verlag
Springer International Publishing
Erschienen in
Current Sleep Medicine Reports / Ausgabe 2/2024
Elektronische ISSN: 2198-6401
DOI
https://doi.org/10.1007/s40675-024-00282-z

Weitere Artikel der Ausgabe 2/2024

Current Sleep Medicine Reports 2/2024 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.